Kathleen M Schmeler1, Michael Frumovitz, Pedro T Ramirez. 1. Department of Gynecologic Oncology, The University of Texas M.D. Anderson Cancer Center, 1155 Herman Pressler Drive, Houston, TX 77030, USA. kschmele@mdanderson.org
Abstract
OBJECTIVES: The utility of parametrial resection in women with early stage cervical cancer is controversial. In patients with favorable pathologic characteristics such as tumor size <2cm and the absence of lymphovascular space invasion, the rate of parametrial involvement is very low. More conservative surgical approaches have therefore been suggested. The objective of this report is to review the existing literature in this area and to describe an ongoing prospective study evaluating the safety and efficacy of conservative surgery in women with early stage cervical cancer. METHODS: We performed a search of PubMed for English language articles published between 1970 and 2010 using the MeSH terms "cervical cancer", "conservative surgery", and "cone biopsy". RESULTS: Several retrospective studies have shown that <1% of patients with early stage cervical cancer with favorable pathologic characteristics have parametrial involvement. In addition, approximately 60% of patients undergoing radical trachelectomy have no residual disease in the final pathologic specimen. Recent studies have reported on the feasibility and safety of performing less radical surgery consisting of pelvic lymphadenectomy with cone biopsy, simple trachelectomy or simple hysterectomy in women with stage IA1 to IB1 cervical carcinoma. In addition, a prospective, multi-center, international trial is currently being performed to evaluate the outcomes of performing pelvic lymphadenectomy with conservative surgery (simple hysterectomy or cervical conization) in patients with favorable pathologic characteristics. Neoadjuvant chemotherapy followed by conservative surgery is also being explored as an option for patients with larger tumors and other pathologic characteristics that do not meet the criteria to perform conservative surgery alone. CONCLUSIONS: The rate of parametrial involvement in women with early stage cervical cancer with favorable pathologic characteristics is low. Should the results of ongoing studies be favorable, conservative surgery could become the standard of care for certain women with early stage cervical cancer.
OBJECTIVES: The utility of parametrial resection in women with early stage cervical cancer is controversial. In patients with favorable pathologic characteristics such as tumor size <2cm and the absence of lymphovascular space invasion, the rate of parametrial involvement is very low. More conservative surgical approaches have therefore been suggested. The objective of this report is to review the existing literature in this area and to describe an ongoing prospective study evaluating the safety and efficacy of conservative surgery in women with early stage cervical cancer. METHODS: We performed a search of PubMed for English language articles published between 1970 and 2010 using the MeSH terms "cervical cancer", "conservative surgery", and "cone biopsy". RESULTS: Several retrospective studies have shown that <1% of patients with early stage cervical cancer with favorable pathologic characteristics have parametrial involvement. In addition, approximately 60% of patients undergoing radical trachelectomy have no residual disease in the final pathologic specimen. Recent studies have reported on the feasibility and safety of performing less radical surgery consisting of pelvic lymphadenectomy with cone biopsy, simple trachelectomy or simple hysterectomy in women with stage IA1 to IB1cervical carcinoma. In addition, a prospective, multi-center, international trial is currently being performed to evaluate the outcomes of performing pelvic lymphadenectomy with conservative surgery (simple hysterectomy or cervical conization) in patients with favorable pathologic characteristics. Neoadjuvant chemotherapy followed by conservative surgery is also being explored as an option for patients with larger tumors and other pathologic characteristics that do not meet the criteria to perform conservative surgery alone. CONCLUSIONS: The rate of parametrial involvement in women with early stage cervical cancer with favorable pathologic characteristics is low. Should the results of ongoing studies be favorable, conservative surgery could become the standard of care for certain women with early stage cervical cancer.
Authors: A Covens; B Rosen; J Murphy; S Laframboise; A D DePetrillo; G Lickrish; T Colgan; W Chapman; P Shaw Journal: Gynecol Oncol Date: 2002-01 Impact factor: 5.482
Authors: Anil K Sood; Ingrid Nygaard; Mark S Shahin; Joel I Sorosky; Susan K Lutgendorf; Satish S C Rao Journal: J Am Coll Surg Date: 2002-10 Impact factor: 6.113
Authors: F Landoni; A Maneo; A Colombo; F Placa; R Milani; P Perego; G Favini; L Ferri; C Mangioni Journal: Lancet Date: 1997-08-23 Impact factor: 79.321
Authors: David Cibula; Jiri Sláma; Jiri Svárovský; Daniela Fischerova; Pavel Freitag; Michal Zikán; Iva Pinkavová; David Pavlista; Pavel Dundr; Martin Hill Journal: Int J Gynecol Cancer Date: 2009-11 Impact factor: 3.437
Authors: Michael Frumovitz; Charlotte C Sun; Kathleen M Schmeler; Michael T Deavers; Ricardo Dos Reis; Charles F Levenback; Pedro T Ramirez Journal: Obstet Gynecol Date: 2009-07 Impact factor: 7.661
Authors: Rene Pareja; Alpa M Nick; Kathleen M Schmeler; Michael Frumovitz; Pamela T Soliman; Carlos A Buitrago; Mauricio Borrero; Gonzalo Angel; Ricardo Dos Reis; Pedro T Ramirez Journal: Gynecol Oncol Date: 2012-01-16 Impact factor: 5.482
Authors: Vaagn Andikyan; Fady Khoury-Collado; John Denesopolis; Kay J Park; Yaser R Hussein; Carol L Brown; Yukio Sonoda; Dennis S Chi; Richard R Barakat; Nadeem R Abu-Rustum Journal: Int J Gynecol Cancer Date: 2014-01 Impact factor: 3.437
Authors: Pedro T Ramirez; Rene Pareja; Gabriel J Rendón; Carlos Millan; Michael Frumovitz; Kathleen M Schmeler Journal: Gynecol Oncol Date: 2013-09-14 Impact factor: 5.482
Authors: Fabio Martinelli; Kathleen M Schmeler; Chelsea Johnson; Jubilee Brown; Elizabeth D Euscher; Pedro T Ramirez; Michael Frumovitz Journal: Gynecol Oncol Date: 2012-07-26 Impact factor: 5.482